It was a happening week for pharma stocks, Key developments this week included a new CAR-T deal for Pfizer PFE, successful study results from Pfizer, Lilly LLY and Allergan AGN and positive regulatory updates from AstraZeneca …
With a market-beating 3.5% yield, great range of new drugs and decent dividend growth since the recession, PFE stock has found its way into plenty of income-seekers portfolios. But the best is yet to come. Thanks to the new GOP tax …
And despite issuing better-than-predicted 2018 guidance, PFE stock fell as much as 2 percent in early morning trading. Heading into the earnings report, Pfizer shares were up 24 percent, matching the gains of the Standard & Poor's 500 …
The dividend is huge at nearly 4%, and PFE buys back stock by the billion as well, meaning it has tremendously high cash needs. Fortunately, for PFE, it enjoys gargantuan FCF margins, so producing cash hasn’t been a problem up to this …
This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether PFE’s current trading price of $35.38 reflective of the actual value of the large-cap?
It is no secret that investors love stock buyback and dividend announcements. Within reason, companies raising dividends and increasing buybacks are particularly loved. Pfizer Inc. (NYSE: PFE) wants its part of the dividend hike and stock …
Pfizer Inc. (NYSE: PFE) reported fourth-quarter and full-year 2017 results ... including the loss of exclusivity on certain products, means that the stock’s performance will be relatively flat again. Even the current dividend yield of nearly 3.5% …
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) reported fourth-quarter earnings Tuesday morning, marginally exceeding earnings expectations and meeting expected revenue numbers. And despite issuing better-than-predicted 2018 …
Pfizer Inc. (NYSE:PFE) isn’t the sexiest stock in the market, but that doesn’t mean investors shouldn’t be interested. PFE stock is up more than 2% in 2017, but down nearly 10% over the past year. Now may be as good a time as any to …
Home Mail News Sports Finance Celebrity Style Movies Weather Answers Flickr Mobile Yahoo